Pheast Therapeutics has treated the first patient in a phase 1 trial of PHST001, a novel macrophage checkpoint inhibitor for advanced solid tumors.

REDWOOD CITY, CA, USA I April 14, 2025 I Pheast Therapeutics, a private biotechnology company developing novel therapies to unleash the power of macrophages ...

Orthodontic treatments often take years, but a breakthrough discovery could drastically shorten this period. Researchers have uncovered that ATF6, a ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed 670,000 in 2022 alone ...

"I don’t know how the future will be for me, but I will keep learning and doing my best to contribute positively to the future of science," Bikram Das said.

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

Deciphering the gut biome's, including helminths', influence on human trained immunity will unlock novel immunotherapies harnessing the immune reprogramming potential of their secreted factors and ...